Chaldakov, GN, Zhelyazkova-Savova, MD, Panayotova, D, Tonchev, AB, Vinciguerra, M, Yanev, SG, Fiore, M and Ghenev, P (2023) Colchicine and therapy of cardiovascular disease: Not merely a theory. Biomedical Reviews, 34. pp. 181-184. ISSN 1310-392X

Preview

Text COLCHICINE AND THERAPY OF CARDIOVASCULAR DISEASE.pdf - Published Version Available under License Creative Commons Attribution. Download (525kB) | Preview

Abstract

The cytoskeleton is a sophisticated cellular system consisted of actin filaments, intermediate filaments and microtubules (MT)
accompanied by a large number of associated structural and motor proteins. Microtubules are dynamically assembling and
disassembling structures. They are pivotal for many cell functions, e.g. intracellular traffic of membrane-bound organelles in
endocytosis and protein secretion, also a variety of inflammatory and signal transduction pathways. Tubulin is the major
building protein of MT. Depended on doses, agents that bind to tubulin inhibit its assembly, that is, MT formation, or disassemble the preformed MT. Such tubulin-binding agents are named MT-disassembling agents or antitululins, colchicine being a
classical member of these agents. Herein, we describe in brief the scientific saga of colchicine as related to the therapy of cardiovascular diseases such as acute coronary syndromes, myocardial infarction, atrial fibrillation, pericarditis, and
hypertrophic cardiomyopathy. Biomed Rev 2023; 34:181-184

Item Type:	Article
Uncontrolled Keywords:	Neurology & Neurosurgery
Subjects:	R Medicine > RS Pharmacy and materia medica
Divisions:	Pharmacy and Biomolecular Sciences
Publisher:	Bulgarian Society for Cell Biology
SWORD Depositor:	A Symplectic
Date Deposited:	16 Jan 2025 14:19
Last Modified:	16 Jan 2025 14:30
DOI or ID number:	10.14748/bmr.v34.9625
URI:	https://researchonline.ljmu.ac.uk/id/eprint/25300

View Item